624 Benefit from maintenance with parp inhibitor in newly diagnosed ovarian cancer according to the mutation type and site
Claudia Marchetti,Anna Fagotti,Robert Fruscio,Chiara Cassani,Lorena Incorvaia,Maria Teresa Perri, Carolina Maria Sassu,Maria De Bonis, Marta Seca, Cristina Angela Camnasio,Elena Giudice,Angelo Minucci, Eloisi Arbustini,Laura Vertechy,Serena Maria Boccia,Vanda Salutari,Maria Gabriella Ferrandina,Lucia Musacchio,Antonio Russo,Giovanni Scambia,Domenica Lorusso Poster and E-Posters（2024）
AI 理解论文
溯源树
样例
